TrialHaematologica2015

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.

Davide Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.